A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
about
Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancerThe quest to overcome resistance to EGFR-targeted therapies in cancer.Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells.Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo.CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.Gene expression profiling for targeted cancer treatment.MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC CellsCD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis.Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death.EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomasThe relationship between EMT, CD44high /EGFRlow phenotype, and treatment response in head and neck cancer cell lines.The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell Lung Cancer.Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations.Drug Resistance Driven by Cancer Stem Cells and Their Niche.Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells.Lower gingival squamous cell carcinoma with brain metastasis during long-term cetuximab treatment: A case report.Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma.GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinomaRelationship between CD44/CD133/CD117 cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines
P2860
Q28488474-DBD425D9-2536-4970-ADDA-C1086C13A233Q33725976-37BAF442-ACBA-4A5C-ABCB-1BC4A1C84379Q34434956-5520C021-ACAF-41AF-A004-A994B7F799DFQ36792380-CCFE17BB-8851-4233-AB26-19B417304704Q36839423-D93092EA-CAF4-4FA6-8956-92A45C107809Q37269588-86CA3436-5BF3-4129-B073-FBB54249CC1DQ37664046-F3D64CBA-59CE-4812-88C0-A04AD64E1878Q38100108-E0914A51-CDF1-4027-A720-7A2990AAF2C0Q38259249-DC6CC5CF-A90F-4E86-B14D-CC1FCB39956CQ38586744-0FAD8306-7593-4ADF-AB0E-D1BFA526F013Q38705051-56C1445D-A1D6-4352-BF44-FCD52C214E8FQ38833083-FCA4F676-1097-4537-AA29-E2C2EB69C8E7Q38872768-CFEF0CFB-8AB5-47F6-B581-E8B510F17E42Q38882381-1855ABAD-2A59-49E7-B873-19D74E26655FQ39111192-841A5B41-CB76-4606-A802-109153E128B4Q40117323-54D643B0-6AF9-4369-BC2C-FD85B2558772Q40203362-BA038958-9E87-4D10-87AB-9584B61D64D3Q42120714-78E4E6D5-58B1-48AE-8890-19CA7C194D52Q42347025-E2A32B1B-98AE-4401-8085-B48B095B8D30Q42371627-7C77BB13-A5BE-4DAD-A113-5135F351AF7AQ47169621-6C10BEE6-3AD1-436F-AC89-0D23661C9D69Q47967656-78A02822-843D-4BF4-BBB3-7A632D4EE00DQ52728022-98BBB1FD-C7D1-4FB5-BB74-604AC988C634Q55090160-42DC2DA6-1709-418C-B20B-BE715E436FFEQ55296915-9DC63201-76B9-48FC-840D-C187C2B508D8Q57069253-9C006E85-9C37-42C8-8965-5E4EEBAEFB75Q58804581-957D69C4-79FB-4F91-8356-FE02ECC24830
P2860
A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@ast
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@en
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@nl
type
label
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@ast
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@en
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@nl
prefLabel
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@ast
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@en
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@nl
P2093
P2860
P1433
P1476
A CD44high/EGFRlow subpopulati ...... e and resistance to treatment.
@en
P2093
Ann-Charlotte Johansson
Karin Roberg
Linnea La Fleur
P2860
P304
P356
10.1371/JOURNAL.PONE.0044071
P407
P577
2012-09-25T00:00:00Z